<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04971564</url>
  </required_header>
  <id_info>
    <org_study_id>FDE-2021-19</org_study_id>
    <nct_id>NCT04971564</nct_id>
  </id_info>
  <brief_title>Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia</brief_title>
  <acronym>RADICAL</acronym>
  <official_title>Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia. A Case-control Trial Nested in a Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this trial is to study, in three well-defined clinical situations responsible for&#xD;
      cerebral hypoxia, the concentrations of biomarkers of thrombo-inflammation compared to a&#xD;
      population of patients without cerebral hypoxia, and to study in patients with cerebral&#xD;
      hypoxia the association between these concentrations and the clinical evolution.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 15, 2021</start_date>
  <completion_date type="Anticipated">March 15, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Biomarker rates at day 0</measure>
    <time_frame>24 hours</time_frame>
    <description>Biomarker: Neutro-Plaket aggregates, extra-cellular DNA networks, von Willebrand Factor</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cerebral Hypoxia</condition>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Case</arm_group_label>
    <description>Patients with cerebral hypoxia victims of ischaemic stroke, acute parenchymal haemorrhage or subarachnoid haemorrhage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Patients without cerebral hypoxia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>Blood sampling will be made to Day 0, Day 3 and to 3 month after inclusion</description>
    <arm_group_label>Case</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated at the Rothschild Foundation Hospital within the first 24 hours of an&#xD;
        acute neurological symptomatology&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admitted to the Rothschild Foundation within the first 24 hours of an acute&#xD;
             neurological symptomatology related to :&#xD;
&#xD;
          -  ischemic stroke eligible for a mechanical thrombectomy procedure&#xD;
&#xD;
          -  subarachnoid haemorrhage due to aneurysmal rupture: patient with at least a modified&#xD;
             Fisher scale 3 or 4 (Appendix 4) and a World Federation of Neurological Surgeons&#xD;
             (WFNS) score of 2 or more&#xD;
&#xD;
          -  intra-parenchymal haematoma with a Glasgow Coma Scale (GCS) strictly below 15.&#xD;
&#xD;
          -  tissue-based transient ischaemic attack - no lesion found on imaging - with ABCD2≥ 2&#xD;
             (control group).&#xD;
&#xD;
          -  Hospitalisation to the Fondation Adolphe de Rothschild Hospital at least 72 hours is&#xD;
             planned&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pre-existing functional and/or cognitive disability&#xD;
&#xD;
          -  Patient under legal protection&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>François DELVOYE</last_name>
    <phone>0148036556</phone>
    <email>fdelvoye@for.paris</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amélie Yavchitz</last_name>
    <phone>0148036556</phone>
    <email>fyavchitz@for.paris</email>
  </overall_contact_backup>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 12, 2021</study_first_submitted>
  <study_first_submitted_qc>July 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>July 22, 2021</last_update_submitted>
  <last_update_submitted_qc>July 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Hypoxia, Brain</mesh_term>
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

